In contrast to breast cancer, significant intra-tumoral heterogeneity of HER2 expression was observed in gastric cancer, and in 4.8%–75.4% of HER2-positive gastric cancer case [15–17]. This evidence concerns the gene ERBB2 and breast cancer.